KalVista Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.83
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-10-31
|
-1.06
|
-0.90
|
0.16
|
15.09%
|
|
2022-07-31
|
-1.04
|
-0.94
|
0.10
|
9.62%
|
|
2022-04-30
|
-1.09
|
-0.98
|
0.11
|
10.09%
|
|
2022-01-31
|
-0.93
|
-0.92
|
0.01
|
1.08%
|
|
2021-10-31
|
-0.79
|
-0.80
|
-0.01
|
-1.27%
|
|
2021-07-31
|
-0.71
|
-0.66
|
0.05
|
7.04%
|
|
2021-04-30
|
-0.56
|
-0.65
|
-0.09
|
-16.07%
|
|
2021-01-31
|
-0.61
|
-0.56
|
0.05
|
8.20%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-10-31
|
-1.84
|
|
2022-04-30
|
-3.36
|
|
2021-04-30
|
-2.40
|
|
2020-04-30
|
-1.64
|
|
2019-04-30
|
-1.41
|
|
2018-04-30
|
-1.56
|
|
2017-04-30
|
-6.62
|
|
2016-04-30
|
-14.55
|
|
2015-04-30
|
-103.32
|